Infektionen des Zentralnervensystems.

  • Beuche W.
  • S. Kastenbauer
  • H.-W. Pfister
  • H. F. Rabenau
  • E. Schielke
  • J. R. Weberx
  • K. Wetzel
  • F. Winkler
Chapter

Zusammenfassung

Die akute Meningitis ist eine Enzündung der Pia mater und der Arachnoidea. Von der noch immer mit einer relevanten Letalität und Morbidität verbundenen akuten bakteriellen (eitrigen) Meningitis ist die akute apurulente oder seröse Meningitis z. B. viraler Genese zu unterscheiden.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anderson M (1993) Management of cerebral infection. J Neurol Neurosurg Psychiatr 56:1243–1258PubMedGoogle Scholar
  2. Camargos PAM, Almeida MS, Cardoso I et al. (1995) Latex particle agglutination test in the diagnosis of Haemophilus influenzae type B, Streptococcus pneumoniae and Neisseria meningitidis A and C meningitis in infants and children. J Clin Epidemiol 48:1245–1250PubMedGoogle Scholar
  3. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) (2003) Meningitis. In: Handbuch Infektionen bei Kindern und Jugendlichen, 4. Aufl. Futura Med, München, S 882–892Google Scholar
  4. Dichgans M, Jager L, Mayer T, Schorn K, Pfister HW (1999) Bacterial meningitis in adults: demonstration of inner ear involvement using high-resolution MRI. Neurology 52:1003–1009PubMedGoogle Scholar
  5. Dodge PR, Davis H, Feigin RD et al. (1984) Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 311:869–874PubMedGoogle Scholar
  6. Dodge PR, Swartz MN (1965) Bacterial meningitis: a review of selected aspects. N Engl J Med 272:1003–1010PubMedGoogle Scholar
  7. Durand ML, Calderwood SB, Weber DJ et al. (1993) Acute bacterial meningitis. A review of 493 episodes. N Engl J Med 328:21–28PubMedGoogle Scholar
  8. Felmingham D, Gruneberg RN (2000) The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45:191–203PubMedGoogle Scholar
  9. Helwig H (1993) Therapie der bakteriellen Meningitis im Kindesalter. Dtsch Ärztebl 90:158–159Google Scholar
  10. Horwitz SJ, Boxerbaum B, O’Bell J (1980) Cerebral herniation in bacterial meningitis in childhood. Ann Neurol 7:524–528PubMedGoogle Scholar
  11. Kastenbauer S, Winkler F, Fesl G, Schiel X, Ostermann H, Yousry TA, Pfister HW (2001) Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis. Arch Neurol: 58:806–810PubMedGoogle Scholar
  12. Koedel U, Pfister HW (1999) Oxidative stress in bacterial meningitis. Brain Pathol 9:57–67PubMedGoogle Scholar
  13. v.
    Kries R, Siedler A, Schmitt HJ, Reinert RR (2000) Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482–487Google Scholar
  14. Lambert HP (1994) Meningitis. J Neurol Neurosurg Psychiatr 57:405–415PubMedGoogle Scholar
  15. Leib SL, Täuber MG (1999) Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 13:527–548PubMedGoogle Scholar
  16. Mclntyre PB, Berkey CS, King SM et al. (1997) Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925–931Google Scholar
  17. Pfister HW (1997) Differentialdiagnose der Meningitis und Enzephalitis. In: Klinik der Gegenwart. Urban&Schwarzenberg, München, VIII, 7:1–30Google Scholar
  18. Pfister HW (2002) Meningitis (Monographie). Kohlhammer, StuttgartGoogle Scholar
  19. Pfister HW, Koedel U, Haberl R et al. (1990) Microvascular changes during the early phase of experimental pneumococcal meningitis. J Cereb Blood Flow Metab 10:914–922PubMedGoogle Scholar
  20. Pfister HW, Borasio GD, Dirnagl U, Bauer M, Einhäupl KM (1992) Cerebrovascular complications of bacterial meningitis in adults. Neurology 42:1497–1504PubMedGoogle Scholar
  21. Pfister HW, Feiden W, Einhäupl KM (1993) The spectrum of complications during bacterial meningitis in adults: Results of a prospective clinical study. Arch Neurol 50:575–580PubMedGoogle Scholar
  22. Pfister HW (1994) Dexamethason-Gabe bei Pneumokokkenmeningitis im Erwachsenenalter: Ein Therapieversuch lohnt. Münchener Med Wochenschr 136:281Google Scholar
  23. Pfister HW, Koedel U, Paul R (1999) Acute meningitis. Curr Infect Dis Rep 1:153–159PubMedGoogle Scholar
  24. Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD (1990) Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med 323:1651–1657PubMedGoogle Scholar
  25. Quagliarello VJ, Scheid WM (1997) Treatment of bacterial meningitis. N Engl J Med 336:708–716PubMedGoogle Scholar
  26. Reinert RR, Labham A, Lemperle M et al. (2002) Emergence of macrolide and penicillin resitance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 49:61–68PubMedGoogle Scholar
  27. Rennick G, Shann F, deCompo J (1993) Cerebral herniation during bacterial meningitis in children. Brit Med J 306:953–955PubMedGoogle Scholar
  28. Roos KL (1998) Bacterial meningitis. In: Roos KL (ed) Central nervous infectious diseases and therapy. Dekker, New York, pp 99–126Google Scholar
  29. Schaad UB, Kaplan SL, McCracken GH Jr (1995) Steroid therapy for bacterial meningitis. Clin Infect Dis 20:685–690PubMedGoogle Scholar
  30. Scheid WM (1984) Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms. Am J Med 76(5A): 193–207Google Scholar
  31. Schuchat A, Robinson K, Wenger JD et al. (1997) Bacterial meningitis in the United States in 1996. N Engl J Med 337:970–976PubMedGoogle Scholar
  32. Swartz MN (1984) Bacterial meningitis: more involved than just the méninges. N Engl J Med 311:912–914PubMedGoogle Scholar
  33. Täuber MG, Khayam-Bashi H, Sande MA (1985) Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 151:528–534PubMedGoogle Scholar
  34. Townsend GC, Scheid WM (1995) Microbe-endothelium interactions in blood-brain barrier permeability during bacterial meningitis. ASM News 61:294–298Google Scholar
  35. Tunkel AR, Scheid WM (1995) Acute bacterial meningitis. Lancet 346:1675–1680PubMedGoogle Scholar
  36. Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, Bertrand JC (1999) High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 28:1313–1316PubMedGoogle Scholar
  37. WHO (2000) Control of epidemic meningococcal disease. WHO Practical Guidelines, 2nd edn. Internet WHO/EMC WebsiteGoogle Scholar
  38. Winkler F, Kastenbauer S, Yousry TA et al. (2002) Discrepancies between brain CT imaging and severely raised intracranial pressure proven by ventriculostomy in adults with pneumococcal meningitis. J Neurol (in press)Google Scholar
  39. Wooley AL, Kirk KA, Neumann AM Jr. et al. (1999) Risk factors for hearing loss from meningitis in children. Arch Otolaryngol Head Neck Surg 125:509–514Google Scholar
  40. Coyle P-K (1999) Overview of acute and chronic meningitis. Neurol Clin 17:691–710PubMedGoogle Scholar
  41. Felgenhauer K, Beuche W (1999) Liquoranalytik und-Zytologie, Diagnose und Prozessmarker. In: Felgenhaue K, Beuche W (Hrsg) Labordiagnostik neurologischer Erkrankungen. Thienne, StuttgartGoogle Scholar
  42. Leib S-L, Tuber M-G (1999) Meningitis (I)-Differenzialdiagnose; aseptische und chronische Meningitis. Ther Umschau 56:631–639Google Scholar
  43. Reiber H (1999) Liquordiagnostik. In: Berlit P (Hrsg) Klinische Neurologie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  44. Tunkel AR (1999) Chronische Meningitis. Curr Infect Dis Rep 1:160–165PubMedGoogle Scholar
  45. Dinsmore S, Dambrosia J, Dalakas MC (1995) A double-blind, placebocontrolled trial of high-dose prednisone for the treatment of postpoliomyelitis syndrome. Ann N Y Acad Sci 25(753): 303–313Google Scholar
  46. Domingues RB, Fink MC, Tsanaclis AM et al. (1998) Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid. J Neurol Sci 157/2:148–153PubMedGoogle Scholar
  47. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC (1981) Guillain-Barré syndrome and the 1978–1979 influenza vaccine. N Engl J Med 304/26:1557–1561PubMedGoogle Scholar
  48. Kaiser R (1999) The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98. Brain 122:2067–2078PubMedGoogle Scholar
  49. Kleinschmidt-DeMasters BK, Gilden DH (2001) Varicella-zoster virus infections of the nervous system. Arch Pathol Lab Med 125:770–780PubMedGoogle Scholar
  50. Lakeman FD, Whitley RJ (1995) Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 171/4:857–863PubMedGoogle Scholar
  51. Meerbach A, Gruhn B, Egerer R, Reischl U, Zintl F, Wutzier P (2001) Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases. J Med Virol 65/2:348–357PubMedGoogle Scholar
  52. Skoldenberg B, Forsgren M, Alestig K et al. (1984) Acyclovir vs. vidarabine in herpes simplex encephalitis. Randomised multicenter study in consecutive Swedish patients. Lancet 29/2 (8405): 707–711Google Scholar
  53. Socan M, Ravnik I, Bencina D, Dovc P, Zakotnik B, Jazbec J (2001) Neurological symptoms in patients whose cerebrospinal fluid is cultureand/or polymerase chain reaction-positive for Mykoplasma pneumoniae. Clin Infect Dis 32/2:E31-35Google Scholar
  54. Stein DP, Dambrosia JM, Dalakas MC (1995) A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. Ann N Y Acad Sci 25(753):296–302Google Scholar
  55. Trojan DA, Collet J-P, Shapiro S et al. (1999) A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology 53/6:1225–1233PubMedGoogle Scholar
  56. Van der Mèche FGA, Schmitz PIM, and the Dutch Guillain-Barré Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 326:1123–1129PubMedGoogle Scholar
  57. Weber T, Frye S, Bodemer M, Otto M, Luke W (1996) Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 2/3:175–190PubMedGoogle Scholar
  58. Whitley RJ, Soong SJ, Linneman C Jr, Liu C, Pazin G, Alford CA (1982) Herpes simplex encephalitis. Clinical Assessment. JAMA 247/3:317–320PubMedGoogle Scholar
  59. Aguzzi A, Collinge J (1997) Post-exposure prophylaxis after accidental prion inoculation. Lancet 350:1519PubMedGoogle Scholar
  60. Aguzzi A, Weissmann C (2001) A suspicious signature. Nature (London) 1996 383:666–667Google Scholar
  61. Aguzzi A. Peripheral prion pursuit. J Clin Invest 108/5:661–662Google Scholar
  62. Anderson RM, Donnelly CA, Ferguson NM et al. (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature (London) 382:779–788Google Scholar
  63. Brown P (1999) Risks posed by human tissue transplants, tissue extracts, and blood. Transmissible Spongiform Encephalopathies Conference, 27-28.10.99, WashingtonGoogle Scholar
  64. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P (1987) The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 37:895–904)PubMedGoogle Scholar
  65. Brown P, Gibbs CJ, Rodgers-Johnson P et al. (1994) Human spongiform encephalopathy: the national Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529PubMedGoogle Scholar
  66. Brown P (1996) Environmental causes of human spongiform encephalopathy. In: Baker HF, Ridley RM (eds) Prion diseases. Humana, Totowa/NJ, pp 139–154Google Scholar
  67. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H (1994) Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc London Ser B 343:405–411Google Scholar
  68. Bruce ME, Will RG, Ironside JW et al. (1997) Transmissions to mice indicate that’ new variant’ CJD is caused by the BSE agent. Nature (London) 389(6650): 498–501Google Scholar
  69. Collee JG, Bradley R (1997) BSE: a decade on — part 1. Lancet 349:636–641PubMedGoogle Scholar
  70. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of »new variant« CJD. Nature (London) 388:685–691Google Scholar
  71. Dealler S (1998) Post-exposure prophylaxis after accidental prion inoculation (letter). Lancet 351:600PubMedGoogle Scholar
  72. Heppner FL, Musahl C, Arrighi I et al. (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294(5540):178–182PubMedGoogle Scholar
  73. Huang Z, Prusiner SB, Cohen FE (1996) Structures of prion proteins and conformational models for prion diseases. In: Prusiner SB (ed) Prions, prions, prions». Springer, Berlin Heidelberg New York Tokyo (Current topics in microbiology and immunology, vol 207)Google Scholar
  74. Lasmezas CI, Foumier JG, Nouvel V et al. (2001) Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci USA 27, 98/7:4142–4147Google Scholar
  75. Löwer J (1996) Creutzfeldt-Jakob-Erkrankung: Zur Diskussion um das Risiko einer Übertragung durch Blut und Blutprodukte. Bundesgesundheitsblatt 8:284–289Google Scholar
  76. Mollenhauer B, Zerr I, Ruge D et al. (2002) Epidemiology and clinical symptomatology of Creutzfeldt-Jakob disease. Dtsch Med Wochenschr 127:312–317PubMedGoogle Scholar
  77. Owen F, Poulter M, Collinge J, Crow TJ (1990) Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet 46:1215–1216PubMedGoogle Scholar
  78. Taylor DM (2001) Resistance of transmissible spongiform encephalopathy agents to decontamination. In: Rabenau HF, Cinatl J, Doerr HW (eds) Prions — a challenge for science, medicine and public health systeme. Karger, Basel, pp 58–67Google Scholar
  79. Uysal A, Kaaden OR (1993) Zum Umgang mit unkonventionellen Erregern. Pathologe 14/6:351–354PubMedGoogle Scholar
  80. Vree PH (1996) Inaktivierung von Prionen. Zentr Steril 4:243–245Google Scholar
  81. WHO (1992) Public health issues related to animal and human spongiform encephalopathies: Memorandum from a WHO meeting. Bull WHO 70/2:183–190Google Scholar
  82. WHO (1998) Blood safety and Creutzfeldt-Jakob disease. Statement issued by the WHO meeting of reginal advisers on blood safety, Geneva, 16 december 1997. WER/REH 1/2:6–7Google Scholar
  83. Will RG, Ironside JW, Zeidler M et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925PubMedGoogle Scholar
  84. Zerr I, Mollenhauer B, Werner C, Poser S (2002) Früh-und Differenzialdiagnose der Creutzfeldt-Jakob Krankheit. Dtsch Med Wochenschr 127:323–327PubMedGoogle Scholar
  85. Zerr I, Poser S (2001) Epidemiology and risk factors of transmissible spongiform encephalopathies (TSE) in man. In: Rabenau HF, Cinatl J, Doerr HW (eds) Prions — a challenge for science, medicine and public health système. Karger, Basel, pp 93–104Google Scholar
  86. Alderson D, Strong AJ, Ingham HR et al.(1981) Fifteen year review of the mortality of brain abscess. Neurosurgery 8:1–6PubMedGoogle Scholar
  87. Anderson M (1993) Management of cerebral infection. J Neurol Neurosurg Psychiat 56:1243–1258PubMedGoogle Scholar
  88. Apuzzo MLJ, Chandrasoma PT, Cohen D, Chi-Shing Zee, Zelman V (1987) Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 20:930–937PubMedGoogle Scholar
  89. Cochrane DD (1999) Consultation with the specialist. Brain abscess. Pediat Rev 20:209–215Google Scholar
  90. Fritz DP, Nelson PB (1997) Brain abscess. In: Roos RL (ed) Central nervous system infectious diseases and therapy. Marcel Dekker, New York, pp 481–497Google Scholar
  91. Henson JW, Ferraro MJ (1993) A 71-year old women with confusion, hemianopia, and an occipital mass. N Engl J Med 329:1335–1341Google Scholar
  92. Juneau P, Black PM (1993) Intra-axial cerebral infectious processes. In: Apuzzo MLJ (ed) Brain surgery, Vol 1. Churchill Livingstone, New York, pp 1411–1414Google Scholar
  93. Levy RM (1994) Brain abscess and subdural empyema. Curr Opinion Neurol 7:223–228Google Scholar
  94. Nau R, Behnke-Mursch J (1999) Diganose und Behandlung des Hirnabszesses. Ther Umschau 11:659–663Google Scholar
  95. Pfister HW (2002) Meningitis (Monographie). Kohlhammer, StuttgartGoogle Scholar
  96. Schielke E (1995) Der bakterielle Hirnabszess. Nervenarzt 66:745–753PubMedGoogle Scholar
  97. Stapleton SR, Bell BA, Uttley D (1993) Stereotactic aspiration of brain abscesses: Is this the treatment of choice?. Acta Neurochir (Wien) 121:15–19Google Scholar
  98. Steiger HJ, Reulen HJ (1999) Manual Neurochirurgie. Ecomed, LandsbergGoogle Scholar
  99. Wispelwey B, Scheid WM (1995) Brain abscess. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 4th edn. Churchill Livingstone, New York, pp 887–900Google Scholar
  100. Wong J, Quint DJ (1999) Imaging of central nervous system infections. Semin Roentgenol 34:123–143PubMedGoogle Scholar
  101. Yamamoto M, Jimbo M, Ide M, Tanaka N, Umebara Y, Hagiwara S (1993) Penetration of intravenous antibiotics into brain abscesses. Neurosurgery 33:44–49PubMedGoogle Scholar
  102. Yang SY, Zhao C (1993) Review of 140 patients with brain abscess. Surg Neurol 39:290–296PubMedGoogle Scholar
  103. Bok APL, Peter JC (1993) Subdural empyema: burr holes or craniotomy? J Neurosurg 78:574–578PubMedGoogle Scholar
  104. Dill SR, Cobbs CG, McDonald CK (1995) Subdural empyema: analysis of 32 cases and review. Clin Infect Dis 20:372–386PubMedGoogle Scholar
  105. Greenlee J (1995) Subdural empyema. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 4th edn. Churchill Livingstone, New York, pp 900–990Google Scholar
  106. Nathoo N, Nadvi SS, van Dellen JR (1997) Infratentorial empyema: analysis of 22 cases. Neurosurgery 41:1263–1269PubMedGoogle Scholar
  107. Nathoo N, Nadvi SS, van Dellen JR, Gouws E (1999) Intracranial subdural empyemas in the era of computed tomography: a review of 699 cases. Neurosurgery 44:529–535PubMedGoogle Scholar
  108. Pathak A, Sharma BS, Mathuriya SN, Khosla VK, Khandelwal N, Kak VK (1990) Controversies in the management of subdural empyema. Acta Neurochir (Wien) 102:25–33Google Scholar
  109. Steiger HJ, Reulen HJ (1999) Manual Neurochirurgie. Ecomed, LandsbergGoogle Scholar
  110. Wagner FC Jr, Preuss JM (1993) Supratentorial epidural abscess and subdural empyema. In: Apuzzo MLJ (ed) Brain surgery, Vol 1. Churchill Livingstone, New York, pp 1401–1409Google Scholar
  111. Gallagher RM, Gross CW, Phillips D (1998) Suppurative intracranial complications of sinusitis. Laryngoscope 108:1635–1642PubMedGoogle Scholar
  112. Nathoo N, Nadvi SS, van Dellen JR (1999) Cranial extradural empyema in the era of computed tomography: a review of 82 cases. Neurosurgery 44:748–753PubMedGoogle Scholar
  113. Osma U, Cureoglu S, Hosoglu S (2000) The complications of chronic otitis media: report of 93 cases. J Laryngol Otol 114:97–100PubMedGoogle Scholar
  114. Pfister HW (2002) Meningitis (Monographie). Kohlhammer, StuttgartGoogle Scholar
  115. Steiger HJ, Reulen HJ (1999) Manual Neurochirurgie. Ecomed, LandsbergGoogle Scholar
  116. Wagner FC Jr, Preuss JM (1993) Supratentorial epidural abscess and subdural empyema. In: Apuzzo MLJ (ed) Brain surgery, Vol 1. Churchill Livingstone, New York, pp 1401–1409Google Scholar
  117. Ameri A, Bousser MG (1992) Cerebral venous thrombosis. Neurol Clin 10:87–111PubMedGoogle Scholar
  118. Bousser MG (2000) Cerebral venous thrombosis: diagnosis and management. J Neurol 247:252–258PubMedGoogle Scholar
  119. DiNubile MJ, Boom WH, Southwick FS (1990) Septic cortical thrombophlebitis. J Infect Dis. 161:1216–1220PubMedGoogle Scholar
  120. Einhäupl KM, Villringer AM, Meister W et al. (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597–600PubMedGoogle Scholar
  121. Pfister HW (2002) Meningitis (Monographie). Kohlhammer, StuttgartGoogle Scholar
  122. Pfister HW, Borasio GD, Dirnagl U, Bauer M, Einhäupl KM (1992) Cerebrovascular complications of bacterial meningitis in adults. Neurology 42:1497–1504PubMedGoogle Scholar
  123. Southwick FS (1995) Septic thrombophlebitis of major durai venous sinuses. Curr Clin Top Infect Dis 15:179–203PubMedGoogle Scholar
  124. Southwick FS, Richardson EPJ, Swartz MN (1986) Septic thrombosis of the durai venous sinuses. Medicine (Baltimore) 65:82–106Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Beuche W.
    • 1
  • S. Kastenbauer
    • 2
  • H.-W. Pfister
    • 2
  • H. F. Rabenau
    • 3
  • E. Schielke
    • 4
  • J. R. Weberx
    • 5
  • K. Wetzel
    • 4
  • F. Winkler
    • 2
  1. 1.Neurologische KlinikStädt. Klinikum St. GeorgLeipzigDeutschland
  2. 2.Neurologische Klinik und PoliklinikKlinikum Großhadern der UniversitätMünchenDeutschland
  3. 3.Institut für Med. VirologieZentrum der Hygiene im Klinikum der Joh.-Wolfg.-Goethe-UniversitätFrankfurt am MainDeutschland
  4. 4.Neurologische KlinikCharité, Campus Mitte, Humboldt-UniversitätBerlinDeutschland
  5. 5.Universitätsklinikum CharitéBerlinDeutschland

Personalised recommendations